object
investig
featur
hepat
b
viru
hbv
basal
core
promoterprecor
bcppc
mutat
genotyp
larg
number
mildsever
chronic
hepat
b
chbmchb
acuteonchron
liver
failur
aclf
patient
analyz
clinic
implic
virolog
featur
patient
method
sera
chbm
chb
aclf
patient
admit
visit
beij
hospit
januari
decemb
collect
success
amplifi
hbv
bcppc
spol
nt
gene
region
biochem
serolog
paramet
hbv
dna
level
routin
perform
viral
dna
extract
subject
nest
pcr
genotypessubgenotyp
determin
base
complet
genom
sequenc
analysi
spolgen
sequenc
hbv
genotyp
perform
direct
pcr
sequenc
follow
molecular
evolutionari
analysi
viral
sequenc
p
valu
twosid
consid
statist
signific
conclus
find
suggest
chb
patient
infect
bcppc
mutant
virus
suscept
sever
hepat
aclf
bcppc
wildtyp
viru
aclf
patient
pc
mutant
virus
increas
risk
death
hbv
pc
mutat
potenti
predict
indic
aclf
outcom
hepat
b
viru
hbv
chronic
infect
million
peopl
worldwid
million
peopl
china
high
risk
evolut
liver
cirrhosi
lc
hepatocellular
carcinoma
hcc
chronic
hbv
infect
lead
wide
spectrum
clinic
present
includ
asymptomat
carrier
state
mild
sever
chronic
hepat
b
chbm
chb
acuteonchron
liver
failur
aclf
china
patient
hepat
brelat
aclf
account
total
aclf
case
due
high
preval
chronic
hbv
infect
without
transplant
patient
high
mortal
rate
result
death
annual
pathogenesi
sever
chronic
hbv
infect
remain
larg
unclear
viral
host
factor
may
play
role
hbv
highli
variabl
viru
classifi
least
eight
genotyp
ah
may
vari
geograph
distribut
viral
characterist
relationship
clinic
outcom
hbv
mutat
basal
core
promot
bcp
precor
pc
region
attract
special
attent
bcp
mutat
may
enhanc
hbv
replic
vitro
pc
mutat
abrog
translat
hbe
antigen
hbeag
consid
toler
protein
buffer
immun
attack
infect
hepatocyt
studi
perform
clarifi
virolog
featur
patient
acut
liver
failur
alf
develop
fulmin
hepat
acut
hbv
infect
occurr
bcp
doubl
mutat
pc
mutat
document
higher
alf
patient
acut
hepat
b
bcppc
mutat
also
report
associ
increas
hbv
replic
capac
andor
reduc
hbeag
express
vitro
case
also
associ
alf
occurr
howev
find
inconsist
date
obviou
link
identifi
hbv
bcppc
mutat
alf
fulmin
hepat
develop
clinic
result
may
partli
due
inadequ
sampl
size
interfer
viral
genotyp
still
pauciti
data
associ
hbv
bcppc
mutat
genotyp
aclf
occurr
liu
et
al
report
virolog
featur
seem
associ
fulmin
subfulmin
exacerb
chb
sampl
size
small
sever
chronic
hbv
infect
may
exhibit
progress
process
ie
chbm
chb
aclf
mani
case
studi
report
investig
featur
hbv
bcppc
mutat
genotyp
larg
number
chbm
chb
aclf
patient
analyz
clinic
implic
virolog
featur
sera
patient
admit
visit
beij
hospit
januari
decemb
collect
success
amplifi
hbv
bcppc
spol
nt
gene
region
patient
cohort
compris
chbm
chb
aclf
patient
patient
came
variou
area
china
mainli
north
countri
diagnost
criteria
base
manag
scheme
diagnost
therapi
criteria
viral
hepat
diagnost
treatment
guidelin
liver
failur
issu
chines
societi
infecti
diseas
parasitolog
chines
societi
hepatolog
respect
describ
previou
studi
briefli
patient
persist
seroposit
hbsag
least
month
enrol
chbm
patient
met
follow
criteria
histori
chronic
hepat
base
histopatholog
diagnosi
andor
compat
laboratori
data
ultrasonograph
find
mild
moder
liver
diseas
activ
reach
criteria
chb
chb
patient
sever
liver
diseas
symptom
includ
obviou
clinic
manifest
signific
alter
biochem
paramet
signific
serum
alanin
aminotransferas
alt
elev
base
biochem
paramet
diagnosi
chb
meet
least
one
follow
criteria
serum
albumin
level
gl
serum
total
bilirubin
tbil
lmoll
plasma
prothrombin
activ
pta
serum
cholinesteras
iul
aclf
patient
met
follow
criteria
recent
develop
increas
jaundic
tbil
lmoll
rapid
increas
lmollday
decreas
pta
recent
develop
complic
hepat
encephalopathi
cgrade
abrupt
obviou
increas
ascit
spontan
bacteri
periton
hepatoren
syndrom
criteria
aclf
wide
use
china
similar
exactli
ident
newli
issu
asian
pacif
associ
studi
liver
apasl
criteria
patient
evid
hcc
metastat
liver
diseas
evid
concomit
hepat
cd
viru
hcvhdv
human
immunodefici
viru
hiv
infect
autoimmun
liver
diseas
studi
approv
ethic
committe
beij
hospit
detect
biochem
serolog
paramet
hbv
dna
level
routin
perform
central
clinic
laboratori
beij
hospit
lower
limit
hbv
dna
detect
copiesml
equival
iuml
detect
bcppc
mutat
viral
dna
extract
subject
nest
pcr
describ
elsewher
primer
gac
gtc
ctt
tgt
yta
cgt
sens
nt
tct
gcg
acg
cgg
cga
ttg
antisens
nt
firstround
pcr
act
tcg
ctt
cac
ctc
tgc
sens
nt
atc
cac
act
cca
aaa
gay
antisens
nt
secondround
pcr
firstround
pcr
consist
equilibr
min
follow
genotypessubgenotyp
determin
base
complet
genom
sequenc
analysi
spolgen
sequenc
amplifi
inhous
nest
pcr
assay
total
hbv
complet
genom
sequenc
individu
patient
use
hbv
genotyp
includ
sequenc
chbm
patient
genbank
access
except
sequenc
chb
patient
except
sequenc
aclf
patient
except
hbv
genotyp
perform
direct
pcr
sequenc
follow
molecular
evolutionari
analysi
viral
sequenc
use
mega
softwar
standard
refer
sequenc
acquir
onlin
hepat
viru
databas
http
wwwncbinlmnih
govprojectsgenotypingformpagecgi
continu
variabl
express
mean
standard
deviat
sd
median
differ
continu
data
evalu
use
student
test
analysi
varianc
anova
nonparametr
wilcoxon
signedrank
test
appropri
categor
data
analyz
use
chisquar
test
fisher
exact
test
multivari
analys
logist
regress
use
determin
independ
factor
statist
analysi
carri
spss
ver
softwar
spss
chicago
il
p
valu
twosid
consid
statist
signific
clinic
background
hbv
genotyp
bcppc
mutat
profil
patient
tabl
summar
clinic
background
hbv
genotyp
bcppc
mutat
three
group
patient
hbv
genotyp
c
b
detect
sampl
patient
respect
domin
subgenotyp
found
individu
genotyp
respect
hbv
genotyp
base
gene
fragment
concord
classif
genotyp
b
c
concord
classif
subgenotyp
comparison
genotyp
base
complet
hbv
genom
slightli
higher
ratio
genotyp
b
c
found
aclf
patient
chb
patient
compar
chb
patient
aclf
patient
significantli
higher
mutat
incid
eight
ten
site
interest
includ
cag
bcp
region
pc
region
notabl
frequenc
hotspot
mutat
averag
substitut
number
ten
site
interest
viral
sequenc
increas
stepwis
manner
three
group
patient
name
chbm
chb
aclf
patient
correspondingli
incid
bcppc
wildtyp
sequenc
decreas
order
addit
two
interest
tripl
bcp
mutat
three
substitut
four
site
frequent
detect
aclf
patient
chb
patient
frequenc
former
tripl
mutat
chbm
chb
aclf
patient
respect
p
frequenc
latter
tripl
mutat
chbm
chb
aclf
patient
respect
p
quadrupl
mutat
detect
four
aclf
case
exclud
potenti
influenc
result
brought
age
differ
among
patient
group
patient
age
year
analyz
independ
two
subset
shown
tabl
patient
differ
ill
categori
similar
age
within
subset
frequenc
averag
substitut
number
remain
significantli
differ
among
three
ill
group
stepwis
increas
order
chbm
chb
aclf
patient
addit
ten
interest
site
signific
differ
variant
frequenc
among
three
ill
categori
also
found
chbm
chb
aclf
p
hbv
genotyp
influenc
bcppc
mutat
rate
analyz
bcp
pc
mutat
genotyp
b
c
virus
individu
tabl
summar
profil
bcppc
mutat
patient
infect
genotyp
b
c
viru
respect
patient
infect
genotyp
b
viru
statist
differ
occurr
mutat
among
three
group
patient
observ
wherea
infect
genotyp
c
viru
signific
differ
four
mutat
among
group
ie
averag
substitut
number
sampl
clearli
increas
stepwis
manner
order
chbschbmaclf
patient
genotyp
b
c
viru
infect
tripl
mutat
pattern
tabl
clinic
featur
hbv
genotyp
bcppc
mutat
profil
patient
enrol
studi
clinic
virolog
characterist
relat
mortal
aclf
patient
patient
aclf
patient
fatal
outcom
patient
surviv
month
onset
liver
failur
older
age
year
higher
tbil
level
lmoll
lower
pta
higher
alt
level
iuml
hbv
pc
mutat
detect
independ
risk
factor
death
tabl
cutoff
valu
median
biochem
paramet
age
year
copiesml
hbv
dna
substitut
numbersampl
select
cutoff
valu
integr
valu
closest
median
outcom
hbv
infect
depend
interplay
viru
hepatocyt
host
immun
respons
hbv
bcppc
mutat
consid
like
involv
drive
factor
diseas
progress
hbv
infect
bcppc
mutat
affect
viral
replic
andor
hbeag
express
may
turn
impact
immun
respons
viru
exampl
propos
express
hbeag
perinat
infect
major
mode
hbv
transmiss
asia
induc
immun
toler
anoth
potenti
role
hbeag
promot
persist
infect
mimic
cp
buffer
immun
attack
infect
hepatocyt
antihbc
antibodi
balanc
disrupt
emerg
hbv
mutant
differ
phenotyp
alter
viruscel
relationship
might
trigger
robust
immun
respons
host
instanc
caus
extens
hepatocyt
necrosi
thu
investig
virolog
featur
may
shed
light
pathogenesi
identifi
predictor
aclf
develop
howev
develop
aclf
relat
multipl
factor
need
studi
extens
clinic
manifest
aclf
differ
fulmin
hepat
basi
acut
hbv
infect
aclf
manifest
also
differ
acut
exacerb
chb
defin
clinic
symptom
along
abrupt
rise
serum
alt
iul
iul
aclf
patient
rel
rare
compar
larg
popul
chb
patient
beij
hospit
one
largest
hospit
infecti
liver
diseas
china
well
known
manag
hepat
b
patient
variou
area
china
come
hospit
seek
treatment
allow
us
collect
larger
sampl
aclf
patient
effici
pcr
amplif
hbv
bcppc
region
greatli
reduc
nickgap
structur
encompass
region
sensit
nest
pcr
assay
lower
limit
detect
copiesml
develop
overcom
obstacl
techniqu
allow
us
analyz
sampl
quit
low
viral
load
previou
sever
acut
respiratori
syndrom
sar
coronaviru
studi
significantli
higher
incid
bcppc
mutat
eight
ten
site
interest
found
aclf
patient
chb
patient
particular
occurr
three
hotspot
bcppc
mutat
averag
substitut
number
ten
site
interest
increas
sever
ill
stepwis
fashion
tabl
suggest
accumul
bcppc
mutat
could
one
drive
factor
ill
sever
take
account
longer
durat
infect
may
increas
incid
hbv
bcppc
mutat
particularli
compar
differ
ill
group
compar
age
minim
factor
result
show
increas
trend
three
hotspot
mutat
diseas
sever
remain
unchang
agematch
patient
tabl
addit
variant
ten
site
interest
frequenc
found
increas
chb
aclf
patient
compar
chbm
patient
suggest
variant
may
also
associ
diseas
sever
report
frequent
detect
hbeagneg
hbv
infect
hbeagposit
hbv
infect
mechan
need
clarif
frequent
bcp
mutat
less
frequent
pc
mutat
detect
genotyp
c
viru
genotyp
b
viru
confirm
previou
result
interestingli
except
case
often
seen
genotyp
b
viru
infect
influenc
hbv
genotyp
sever
hbv
infect
still
uncertain
genotyp
b
c
virus
differ
bcppc
mutat
featur
influenc
clinic
outcom
may
associ
bcppc
mutat
nevertheless
averag
substitut
number
per
sampl
bcppc
region
clearli
increas
sever
ill
categori
genotyp
b
c
suggest
accumul
bcppc
mutat
increas
risk
aclf
occurr
regardless
hbv
genotyp
report
coexist
may
enhanc
viral
replic
vitro
associ
alf
advanc
liver
diseas
found
andor
tripl
mutat
frequent
aclf
patient
chb
patient
suggest
highli
replic
strain
bcp
mutat
also
like
associ
aclf
develop
among
case
triplet
b
pattern
nine
notic
last
pattern
document
earlier
mainli
occur
aclf
patient
luciferas
report
system
natur
mutant
sequenc
proven
higher
transcript
regul
activ
averag
wildtyp
sequenc
gener
revers
sitedirect
mutagenesi
data
shown
suggest
bcp
mutat
frequent
emerg
late
hbeag
phase
infect
wherea
pc
mutat
usual
emerg
later
height
antihb
immun
respons
therefor
classifi
three
bcppc
mutat
status
bcppc
bcp
pcand
analyz
implic
result
show
chbm
patient
infect
bcppc
mutant
exhibit
enhanc
inflammatori
respons
signific
increas
tbil
alt
level
slight
decreas
viral
load
bcppc
wildtyp
viru
wherea
chb
aclf
patient
contrast
chb
patient
infect
bcppc
mutant
lower
tbil
hbv
dna
level
wildtyp
viru
date
studi
abl
show
associ
clinic
paramet
hbv
bcppc
mutat
bcp
mutant
shown
posit
correl
increas
alt
level
chronic
hbv
carrier
chb
patient
reduc
viremia
associ
bcppc
mutant
explain
fact
enhanc
hbv
replic
mutant
would
effici
stimul
immun
reaction
lead
enhanc
destruct
viral
particl
altern
alt
hbv
dna
level
may
influenc
use
antivir
treatment
furthermor
blood
test
singl
time
point
may
bia
evalu
diseas
activ
chb
patient
fluctuat
alt
hbv
dna
level
although
influenc
rel
proportion
larges
sampl
studi
genotyp
phenotyp
studi
need
perform
make
clearer
outlin
rate
hbeag
loss
antihb
posit
increas
stepwis
manner
along
emerg
bcp
mutat
pc
mutat
chbm
patient
chb
aclf
patient
bcp
mutat
alon
significantli
increas
hbeagnegativeantihbeposit
rate
suggest
bcp
mutat
may
divers
influenc
hbeag
seroconvers
differ
ill
categori
report
bcp
doubl
mutat
associ
lower
viral
load
hbeagposit
individu
pc
mutat
correl
high
level
hbv
dna
hbeagneg
chb
patient
howev
associ
observ
studi
data
shown
mutant
virus
frequent
coexist
wildtyp
virus
subpopul
compris
total
hbv
popul
may
miss
direct
sequenc
techniqu
may
account
detect
mutant
hbeagposit
patient
interestingli
found
aclf
patient
infect
pc
mutant
significantli
higher
mortal
pc
wildtyp
hbv
indic
hbv
pc
mutat
could
serv
predict
indic
aclf
outcom
summari
find
suggest
chb
patient
infect
bcppc
mutant
viru
suscept
sever
hepat
aclf
bcppc
wildtyp
viru
aclf
patient
pc
mutant
viru
increas
risk
death
result
studi
knowledg
virolog
factor
associ
sever
chronic
hbv
infect
